PDF
ePub
Citation
Print
Abstract
Since early gastric cancer (EGC) patients show an excellent surgical outcome and a longterm survival rate, the purpose and methods of postoperative followup need to be reconsidered. The recurrence rate after surgery is less than 2% in EGC. The mode of recurrence is diverse, of which hematogeous metastasis being most frequently encountered. Post-gastrectomy patients have a risk of nutritional deficiency and more chances to develop remnant gastric tumor or secondary tumor than normal population. Based on the pattern and developmental time span of recurrence, postoperative followup program for EGC should not be different from that for advanced gastric cancer. Most Korean doctors? postoperative followup with the patients range up to 5 years with an interval of 4 to 6 months. Gastroscopy, CT, and tumor markers are used for followup by more than 50% of doctors. Due to the increased rate of longterm survival, followup program should include assessment of functional aspect and nutritional well-being of the patients. Epidemiological studies for the longterm survivors and specialized strategies need to be developed for management of postgastrectomy cancer patients. Although early detection of recurrence is the primary goal of postoperative followup, postgastrectomy patients should be recognized as a risk group in terms of nutritional and medical problems on a life-long basis, and longterm management strategy should be developed.
REFERENCES
1. The Information Committee of the Korean Gastric Cancer Association. 2004 Nationwide Gastric Cancer Report in Korea. J Korean Gastric Cancer Assoc. 2007; 7:47–54.
2. Yang HK. Information Committee of the Korean Gastric Cancer Association. Current Status of Clinical Practice for Gastric Cancer Patients in Korea. J Korean Gastric Cancer Assoc. 2004; 4:95–108.
3. Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer. 1993; 72:3174–3178.
4. Lee HJ, Kim YH, Kim WH, Lee KU, Choe KJ, Kim JP, Yang HK. Clinicopathological analysis for recurrence of early gastric cancer. Jpn J Clin Oncol. 2003; 33:209–214.
5. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003; 90:1113–1119.
6. Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, Ito K, Akiyama S, Nakao A. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol. 2003; 10:898–902.
7. Ahn HS, Kim JW, Yoo MW, Park do J, Lee HJ, Lee KU, Yang HK. Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy. Ann Surg Oncol. 2008; 15:1632–1639.
8. Sasako M, Maruyama K, Kinoshita T, Okabayashi K. Surgical treatment of carcinoma of the gastric stump. Br J Surg. 1991; 78:822–824.
9. Newman E, Brennan MF, Hochwald SN, Harrison LE, Karpeh MS Jr. Gastric remnant carcinoma: just another proximal gastric cancer or a unique entity? Am J Surg. 1997; 173:292–297.
10. Otsuji E, Kobayashi S, Okamoto K, Hagiwara A, Yamagishi H. Is timing of death from tumor recurrence predictable after curative resection for gastric cancer? World J Surg. 2001; 25:1373–1376.
11. An JY, Youn HG, Choi MG, Noh JH, Sohn TS, Kim S. The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg. 2008; 196:587–591.
12. Buhl K, Schlag P, Herfarth C. Quality of life and functional results following different types of resection for gastric carcinoma. Eur J Surg Oncol. 1990; 16:404–409.
13. Bechtold ML, Holly JS, Thaler K, Marshall JB. Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare? World J Gastroenterol. 2007; 13:4091–4095.
14. Hakanson BS, Berggren P, Granqvist S, Ljungqvist O, Thorell A. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring. Scand J Gastroenterol. 2009; 44:276–283.
15. Marshall RE, Anggiansah A, Owen WA, Owen WJ. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut. 1997; 40:182–187.
16. Dickman R, Fass R. Ambulatory esophageal pH monitoring: new directions. Dig Dis. 2006; 24:313–318.
17. Hsu CP, Chen CY, Hsieh YH, Hsia JY, Shai SE, Kao CH. Esophageal reflux after total or proximal gastrectomy in patients with adenocarcinoma of the gastric cardia. Am J Gastroenterol. 1997; 92:1347–1350.
18. Stein HJ, Hinder RA, DeMeester TR, Lloyd BA, Fuchs KH, Attwood SE, Gupta NC. Clinical use of 24-hour gastric pH monitoring vs o-diisopropyl iminodiacetic acid (DISIDA) scanning in the diagnosis of pathologic duodenogastric reflux. Arch Surg. 1990; 125:966–970. discussion 970-961.
19. Nunobe S, Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Symptom evaluation of longterm postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer. Gastric Cancer. 2007; 10:167–172.
20. Park do J, Lee HJ, Jung HC, Kim WH, Lee KU, Yang HK. Clinical outcome of pylorus-preserving gastrectomy in gastric cancer in comparison with conventional distal gastrectomy with Billroth I anastomosis. World J Surg. 2008; 32:1029–1036.
21. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008; 372:392–397.
22. Caygill CP, Hill MJ, Kirkham JS, Northfield TC. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet. 1986; 1:929–931.
23. Fujiwara T, Hirose S, Hamazaki K, Iwagaki H, Mano K, Orita K. Clinicopathological features of gastric cancer in the remnant stomach. Hepatogastroenterology. 1996; 43:416–419.
24. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Gastric remnant carcinoma after partial gastrectomy for benign and malignant gastric lesions. J Am Coll Surg. 1996; 182:1–6.
25. Sinning C, Schaefer N, Standop J, Hirner A, Wolff M. Gastric stump carcinoma-epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol. 2007; 33:133–139.
26. Seto Y, Nagawa H, Muto T. Prognostic significance of non-gastric malignancy after treatment of early gastric cancer. Br J Surg. 1997; 84:418–421.
27. Ikeda Y, Saku M, Kishihara F, Maehara Y. Effective followup for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg. 2005; 92:235–239.
28. Liedman B, Andersson H, Bosaeus I, Hugosson I, Lundell L. Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial. World J Surg. 1997; 21:416–420. discussion 420-411.
29. Kiyama T, Mizutani T, Okuda T, Fujita I, Tokunaga A, Tajiri T, Barbul A. Postoperative changes in body composition after gastrectomy. J Gastrointest Surg. 2005; 9:313–319.
XML Download